Evidence Explorer · MS-N051

Tai Chi Chih compared with CBT-I for insomnia after breast cancer

Family: Mind–body movement and sleep supportive care
Clinical question: For breast-cancer survivors with insomnia, can Tai Chi Chih produce durable insomnia improvement comparable with CBT-I?
Evidence label: Encouraging noninferiority trial; subjective benefit without objective sleep improvement.

Evidence at a glance

• Benefit: At 15 months, insomnia response was similar in the Tai Chi Chih and CBT-I groups.
• Certainty: One small active-comparator noninferiority trial with attrition; no inactive control.
• Risk: Usually low, but balance, neuropathy, pain, cardiopulmonary limits, and bone fragility require adaptation.
• Cancer control: Not studied; inflammation findings from later analyses are not cancer-control evidence.

What was studied

Ninety breast-cancer survivors with insomnia were randomized to CBT-I (45) or a standardized Tai Chi Chih program (45). After a two-month phase-in, treatment continued for three months, with outcomes assessed at 3, 6, and 15 months.

What the evidence shows

At 15 months, insomnia response was 43.7% with CBT-I and 46.7% with Tai Chi Chih; the noninferiority test met the study criterion (P=.02). Remission was 46.2% and 37.9%, respectively. Subjective sleep, fatigue, and depressive symptoms improved in both groups, while polysomnography did not show corresponding objective sleep changes. Forty CBT-I participants and 33 Tai Chi Chih participants were observed at 15 months.

What this does not show: This does not establish that tai chi is superior to CBT-I, that either intervention changes cancer biology, or that biomarker changes translate into recurrence or survival benefit.

Limits and uncertainty

• Only 90 participants, with fewer observed at 15 months.
• An active-comparator design cannot estimate benefit over no intervention.
• Subjective improvements were not confirmed by polysomnography.
• The intervention was Tai Chi Chih, a particular standardized form; findings should not be generalized to every tai chi or qigong program.
• A published erratum should be read with the original report.

Safety and practical context

An adapted, supervised form is sensible for people with neuropathy, dizziness, joint limitations, cardiopulmonary disease, or bone metastases. Tai chi should complement—not postpone—assessment for sleep apnea, medication effects, pain, hot flashes, mood disorders, or other treatable causes.

Questions for the care team

• Would CBT-I be more accessible or appropriate?
• Is the instructor prepared to adapt movement for balance, neuropathy, lymphedema, and bone health?
• Is objective sleep testing needed?
• What outcome and time point will define success?

Sources

• Primary noninferiority trial (J Clin Oncol; PMID 28489508)
• Full text (PMCID PMC5549450)
• Published erratum (PMID 29244979)
• Later inflammatory-marker analysis (PMID 38777285)

Identifiers: PMID 28489508; PMCID PMC5549450; DOI 10.1200/JCO.2016.71.0285; erratum PMID 29244979
Last literature search: October 17, 2026
Record appraised: October 17, 2026

Educational information, not personal medical advice. Decisions about symptoms, supplements, movement, or psychological care during cancer treatment should be made with the oncology team.